HomeORX • STO
add
Orexo AB
Nakaraang pagsara
kr 40.80
Sakop ng araw
kr 37.40 - kr 41.30
Sakop ng taon
kr 9.18 - kr 43.40
Market cap
1.32B SEK
Average na Volume
97.68K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (SEK) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 118.20M | -23.25% |
Gastos sa pagpapatakbo | 128.10M | -18.09% |
Net na kita | -39.80M | -10.86% |
Net profit margin | -33.67 | -44.44% |
Kita sa bawat share | -1.15 | -10.58% |
EBITDA | -6.90M | -428.57% |
Aktuwal na % ng binabayarang buwis | -17.40% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (SEK) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 121.30M | -13.17% |
Kabuuang asset | 533.40M | -31.02% |
Kabuuang sagutin | 730.40M | -2.50% |
Kabuuang equity | -197.00M | — |
Natitirang share | 34.71M | — |
Presyo para makapag-book | -7.18 | — |
Return on assets | -8.61% | — |
Return on capital | -14.73% | — |
Cash Flow
Net change in cash
| (SEK) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -39.80M | -10.86% |
Cash mula sa mga operasyon | -700.00K | 89.23% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 4.50M | 109.38% |
Net change in cash | 2.20M | 103.77% |
Malayang cash flow | 36.26M | 894.79% |
Tungkol
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
Itinatag
1995
Website
Mga Empleyado
110
